Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

ASO-RASAR: A Read-Across Framework for Predicting Antisense Oligonucleotide Gapmer Activity Across Target Genes.

Journal of chemical information and modeling·2026

Same author

Curvature-Conforming Nanostructured Encapsulation for Washable and Mechanically Reliable Fiber OLEDs.

ACS applied materials & interfaces·2026

Same author

A review of animal-assisted therapy for older adults in Korea: effects on depression and cognitive function and implications for practice.

Journal of animal science and technology·2026

Same author

High-performance thermally-robust C-band GeSi FK electro-absorption modulators on 300-mm silicon photonics platform.

Optics express·2026

Same author

Development of an Artificial Intelligence Model to Predict Endotracheal Intubation in Critically Ill Patients in Real Time.

Journal of clinical medicine·2026

Same author

Chamber-Specific Decellularized Extracellular Matrices Differentially Modulate Cardiomyocyte Subtypes to Drive Engineered Heart Tissue Development and Function.

Advanced healthcare materials·2026

Search research articles

相关实验视频

Updated: Sep 20, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

通过使用重新设计的BARR方法进行高效采样来提高结合亲和力预测:对GPCR目标进行测试.

Minkyu Kim¹, Jian Jeong¹, Donghwan Kim²

¹inCerebro 8F Nokmyoung Bldg, 8 Teheran-ro 10-gil, Gangnam-gu Seoul Korea 06234 artcho@incerebro.com.

Chemical science

|May 30, 2025

概括

此摘要是机器生成的。

这项研究通过改进分子模拟采样,增强了对联体受体结合亲缘关系的预测. 重新设计的贝内特接受率 (BAR) 方法与膜蛋白的实验数据有很强的相关性.

更多相关视频

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates

Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates

Published on: December 6, 2017

相关实验视频

Last Updated: Sep 20, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates

Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates

Published on: December 6, 2017

科学领域:

计算化学的计算化学
分子动力学分子动力学
结构生物学结构生物学

背景情况:

通过计算预测连接体-受体结合亲和力是至关重要的,但在分子模拟中样本采集不足往往受到限制.
由于采样限制,现有的方法难以准确验证实验结果.
重新采样分子轨迹是克服这些挑战的关键策略.

研究的目的:

提出和验证一种用于高效分子采样的新型模拟协议.
为了提高采样效率,重新设计贝内特接受率 (BAR) 方法.
评估该协议在包括GPCR在内的多种膜蛋白标中的性能.

主要方法:

重新设计贝内特接受率 (BAR) 方法以提高采样效率.
将修改后的BAR方法应用于膜蛋白点的分子动力学模拟.
在已知结合亲和性的G蛋白合受体 (GPCR) 上测试该协议.

主要成果:

拟议的模拟协议实现了对复杂分子系统的有效采样.
基于BARR的有约束力的自由能量计算显示出与实验数据有很强的相关性.
该方法证明对各种膜蛋白点有效,包括各种GPCR.

结论:

重新设计的BARR方法提供了一种有效和高性能计算方法,用于绑定亲和力预测.
该协议提高了用于药物发现和生物物理学的分子模拟的准确性和可靠性.
该研究验证了增强型采样协议在具有挑战性的膜蛋白标中有效的适用性.